BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Childhood Cancers
NCI Information
Our Treatment Approach
Clinical Trials
Support Groups
Late Effects of Treatment
Patient Stories
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
COG ANBL0032
Principal Investigator:
Wilson, David
Title:
Phase III Randomized Study of Chimeric anti-GD2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Phase:
III
Disease Site:
Multiple Sites
Participating Site(s):
Main Campus
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
To determine if monoclonal antibody CH14.18 + cytokines + 13 cis-RA improved event free and overall survival after myeloablative therapy and stem cell rescue as compared to RA alone.
More Information:
(Links will take you off this web site)
Internal Protocol Documents (requires Siteman administrative database password)